CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
TrAVeRse is a multicentre, open-label, Phase II study of AVR in treatment naïve MCL participants. The primary objective will be to assess the rate of...
Phase 2
Warszawa, Poland and 28 other locations
on participants who have one of two types of cancer: follicular lymphoma (FL) or marginal zone lymphoma (MZL) that has come back af...
Phase 3
Warsaw, Poland and 143 other locations
dose of BGB-11417 monotherapy for relapsed or refractory mantle cell lymphoma. Part 2 evaluates efficacy of BGB-11417 monotherapy at the rec...
Phase 1, Phase 2
Warszawa, Poland and 103 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Warszawa, Poland and 215 other locations
to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...
Phase 2
Warszawa, Mazowieckie, Poland and 67 other locations
The purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemoth...
Phase 3
Warszawa, Poland and 143 other locations
choice in participants with relapsed/refractory follicular lymphoma who have received at least one line of prior systemic therapy....
Phase 3
Warszawa, Mazowieckie, Poland and 144 other locations
the safety, tolerability, and preliminary clinical activity of Tulmimetostat as a monotherapy in patients with advanced solid tumors and lymphomas...
Phase 1, Phase 2
Warsaw, Poland and 62 other locations
The purpose of this trial is to measure the following in participants with relapsed and/or refractory B-cell lymphoma who receive epcoritama...
Phase 1, Phase 2
Warszawa, Poland and 84 other locations
2 cohorts to assess safety and efficacy of emavusertib in combination with ibrutinib in participants with R/R primary central nervous system lymphoma...
Phase 1, Phase 2
Warsaw, Poland and 42 other locations
Clinical trials
Research sites
Resources
Legal